Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2025-12-24 @ 5:52 PM
NCT ID:
NCT02799368
Eligibility Criteria:
Inclusion Criteria:
* Individuals aged 18 years or older
* with eGFR \< 45 mL/min/1.73m2 or eGFR \< 60 mL/min/1.73m2 who have at least one condition Diabetes mellitus Age \> 60 year
* Able and willing to provide informed consent
Exclusion Criteria:
* eGFR \< 15 mL/min/1.73m2 or end stage renal disease patients with dialysis history
* Heart failure with left ventricular ejection fraction \< 45% or severe symptoms (New York Heart Association functional classification III or IV)
* Decompensated heart failure patients who use dobutamine, dopamine, milrinone, amrinone, nesiritide or patients who have acute pulmonary edema
* History of hyperkalemia (serum K \> 5.5 mEq/L) or hypernatremia ( serum Na \> 145 mEq/L) in screening period
* Recent exposure to radiocontrast within 7 days of the study
* History of hypersensitivity to radiocontrast
* Multiple myeloma
* Pregnant/lactation
* Expected survival \< 6 months
* Enrolled in other clinical trials
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02799368
Study Brief:
Protocol Section:
NCT02799368